Administration of rIL-33 treatment to malaria-infected mice has been shown to reduce the MDSC (CD11b+Gr1+) population in the spleen 8 days post-infection by flow cytometric analysis (Figure 4A,B). The gene discussed is ITGAM; the disease is malaria.